Keeps Biopharma Inc. (KOSDAQ:256940)
South Korea
· Delayed Price · Currency is KRW 8,170.00
+730.00 (9.81%)
At close: Mar 6, 2026
Keeps Biopharma Revenue
Keeps Biopharma had revenue of 40.93B KRW in the quarter ending September 30, 2025, with 29.81% growth. This brings the company's revenue in the last twelve months to 157.75B, up 25.44% year-over-year. In the year 2024, Keeps Biopharma had annual revenue of 127.58B with 38.48% growth.
Revenue (ttm)
157.75B
Revenue Growth
+25.44%
P/S Ratio
0.95
Revenue / Employee
1.45B
Employees
109
Market Cap
150.18B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DSK Co., Ltd. | 42.90B |
| C&G Hi Tech | 183.90B |
| Dong A Eltek | 396.06B |
| HB SOLUTION | 96.23B |
| DMS Co.,Ltd. | 199.65B |
| HB Technology CO.,LTD. | 137.50B |
| HMNEX | 13.42B |
| PIE Co., LTD. | 90.68B |